AMSA Pharm-free Scorecard 2010
A Mayo Medical School - College of Medicine
City: Rochester State: MN

As a whole, this institution’s policies are exemplary. Strong policies with defined areas that many other schools do not address are the norm for Mayo. Notable policies include those governing gifts, consulting relationships, and pharmaceutical samples. The inclusion of outstanding curriculum materials also is a highlight. 

This institution submitted additional policies for curriculum for the 2012-13 AMSA PharmFree Scorecard.

This institution's evaluation was last updated: 4/9/2013.



Gifts & Meals 3 The policy clearly prohibits all offers of gifts from vendors, particularly personal (promotional) gifts. Food is also not to be provided directly by suppliers, other industries or individuals conducting business with the academic medical center but as grants.
Consulting relationships 3 An extremely detailed and comprehensive policy. Consulting is permitted, with various restrictions, including review of all relationships by the Medical-Industry Relations Committee. Prior to the start of all formal consulting relationships, a contract clearly describing the services to be provided at fair market value must be signed by all parties (including Mayo). For consulting relationships with fees that are >$10,000 per company per year or per activity, quarterly invoices describing all activities, payments and time spent must be submitted to the Medical-Industry Relations Committee as long as the relationship lasts. If the consultant is also conducting concurrent research with the same company, the consulting fees must be paid through the Foundation for Medical Education and Research, and will from there be allocated to the consultant.
Industry-funded speaking relationships 2 It appears that most speaking engagements fall under the detailed consulting rules, with speaker's bureaus being explicitly banned. However, nowhere does this policy clearly state that industry is not permitted to control presentation content.
Disclosure 3 Information on potential COI existing between AMC staff and industries are included in patient information material.
Pharmaceutical samples 3 Samples are not permitted except for investigational purposes that are approved by IRB research protocols.
Purchasing & Formularies 3 Members of the Pharmaceutical Formulary Committee must recuse themselves from any decision regarding a commercial entity with whom they have a financial relationship.
Industry Sales Representatives 2 Industry representatives are only permitted to enter the facility with a scheduled appointment.
On-campus Education 2 All CME activities planned by the institution’s School of CME are subject to institutional review. All industry funding must come in the form of educational grants, which the course director will direct.
Attendance at Industry-Sponsored Lectures & Meetings Off-Campus 3 Citing AMA guidelines, the institution does not allow direct or indirect subsidies to pay the costs of travel, meals or lodging for conference attendees.
Industry Support for Scholarships & Funds for Trainees 3 Unrestricted funds may be provided to Mayo for use as scholarships for attendance at conferences provided the recipient of the funds is chosen by the program director.
Medical school curriculum 3 In the exemplary curriculum materials provided, Mayo Medical School showed that one of its major educational goals is to fully educate students on both how conflicts of interest arise and what the institutional policies are. Curricular material target various faculty, administrative staff and graduate level students.
Do the policies specify an oversight mechanism? Yes There are clear parties for oversight. Mayo also has both a Compliance Hotline and an Internet reporting site for anonymous reporting of offences.
Are there explicit sanctions for noncompliance? Yes Sanctions for non-compliance are clearly outlined.
What the results mean...
3Model policy
2Good progress toward model policy
1No policy, or policy unlikely to have a substantial effect on behavior
0Did not report
N/APolicy not relevant to this institution (e.g., does not make purchasing decisions)